Advertisement
Wednesday, November 11, 2026NewslettersAdvertiseWatch FL1
GET LOCALGo ad-freeHigh school sportsLocal eventsObituaries
News

Cornell gets $7.5M to improve antibiotic tracking in animals

A five-year FDA grant will help Cornell researchers develop privacy-protecting tools to measure antimicrobial use in livestock and pets.

Cornell gets .5M to improve antibiotic tracking in animals

Cornell researchers are developing a way to track antimicrobial use in livestock and pets while protecting farmers’ and veterinarians’ private information, backed by a five-year, $7.5 million grant from the Food and Drug Administration.

The project aims to close gaps in how antibiotic use is measured and shared, giving animal caretakers better information for treatment decisions and helping researchers understand antibiotic resistance, according to a Nov. 11 report by Krishna Ramanujan in the Cornell Chronicle.


Building trust while protecting private records

The effort is led by Dr. Renata Ivanek, a professor of population medicine and diagnostic sciences in Cornell’s College of Veterinary Medicine. Researchers plan to bring together antimicrobial-use statistics from dairy farms, poultry operations and companion animal veterinary practices, with beef and swine producers ultimately included as well.

Collecting those records presents both technical and human challenges. Existing information is fragmented, measurements differ across sectors, and farmers and veterinarians may be reluctant to share details about treatment decisions.

“We cannot manage how antimicrobials are used in animals unless we can measure, and we cannot measure because data are fragmented, siloed and unstandardized and there are no incentives for data sharing, and so there are these big hurdles about trust,” Ivanek told the Chronicle.

Some participants worry that peers, regulators, consumers or clients could interpret their records as evidence of too much or too little antibiotic use without understanding why an animal was treated — or why treatment was withheld.

The researchers propose a system that would aggregate information where the underlying records are held, then send the combined statistics to a secure repository. The approach is intended to keep individual information private while making broader patterns available for analysis.

A planned dashboard could provide national and local averages. Approved users could compare their own antimicrobial use with those benchmarks, potentially gaining information to guide treatment decisions or identify questions that need further research.

Moving beyond sales totals

Pharmaceutical companies’ sales figures, reported by tonnage, are currently the main source of antimicrobial-use data because more detailed records have been difficult to obtain, according to Cornell. Those totals offer an imprecise measure of how and why the medicines are used.

Other approaches also leave gaps. Use may be recorded in milligrams, doses or veterinary treatment visits, with each measure capturing only part of the picture. The project will explore a common metric that could work across different animal-care sectors.

Its goals also include governance shaped by the people contributing data, alongside technology designed to protect their privacy. Researchers hope that offering useful information in return will give farmers and veterinarians a reason to participate.

The bigger picture

Agriculture

More reporting on this topic.

Explore this topic →

Understanding antibiotic resistance

Bacteria can acquire antibiotic resistance through genetic mutations or by exchanging genes. Antibiotic treatment can kill susceptible bacteria while allowing resistant bacteria to survive and multiply.

Resistant bacteria can affect people, livestock and companion animals. They can also reach people through food, animal contact and the environment. Antibiotic use in people contributes to resistance as well, Cornell’s report notes.

One aim of the grant is to help distinguish how much antibiotic use in animals may influence the development of resistant bacteria in animals and humans. The repository and dashboard are proposed tools; the source does not report that they are already operating or that the project has demonstrated a reduction in resistance.

Co-principal investigators include Cornell veterinary faculty Dr. Daryl Nydam and Dr. Casey Cazer; Steven Wolf, Kurt Waldman and danah boyd from the College of Agriculture and Life Sciences; and Daniel Susser, Hakim Weatherspoon, Christopher De Sa, Immanuel Trummer and Jennifer Sun from Cornell Bowers Computing and Information Science. Dr. Randall Singer of Mindwalk Consulting Group and Dr. Jennifer Granick of the University of Minnesota are also co-principal investigators.



Want to go ad-free?

Become an FL1 member and say goodbye to ads! Plus, you’ll be supporting a company rooted in the Finger Lakes for nearly 30 years.

$4.99 / month

Get ad-free access

Renews monthly. Cancel anytime through your account. Already contributing via Google? Sign in with your Google account and unlock ad-free access. Embedded YouTube videos and other third-party media players may still contain ads.

Start your day with FingerLakes1

Get the stories that matter from across the Finger Lakes, delivered to your inbox.

Your email will be added to our newsletter mailing list, hosted on Substack. Privacy policy